Skip to main content
lexblog.com/lib/XG7KV4WBviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Failure-to-Warn Claim Targeting Branded Drug Held Preempted:  Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation",
    "url": "https://www.lexblog.com/2022/09/19/failure-to-warn-claim-targeting-branded-drug-held-preempted-litigation-driven-expert-analysis-is-not-newly-acquired-information-for-purposes-of-the-changes-being-effe/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-XG7KV4WB",
        "url": "https://www.lexblog.com/lib/XG7KV4WB/"
    },
    "datePublished": "2022-09-19T05:00:00-04:00",
    "dateModified": "2022-12-01T10:07:38-05:00",
    "author": {
        "@type": "Person",
        "name": "Andrew Tauber"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Drug & Device Law Blogging Team"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Drug & Device Law",
    "about": "Other",
    "sourceUrl": "https://www.druganddevicelawblog.com/?p=26718",
    "sourceStability": "may-move"
}